CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

计划入组 24 人 · 首次发布于 2024 年 4 月 10 日

Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers

计划入组 11 人 · 首次发布于 2015 年 8 月 18 日

PREVENT HPV -Related Cancers Trial

计划入组 1,455 人 · 首次发布于 2025 年 10 月 15 日

HPV-X

HPV CD40 HVac

SQZ-PBMC-HPV

ASSO DE RECHERCHE CANCERS GYNECOLOGIQUES

France

Merck & Co Inc

United States

Marinus Pharmaceuticals

United States

Transgene's Immunotherapy Pipeline Advances with Key Data Readouts Expected in Q4 2024

Merck's Gardasil 9 Shows Positive Phase 3 Results in Japanese Males

PDS Biotech's Versamune Shows Promise in HPV-Positive Cancers